Building an Integrated and Future-ready Regulatory System for Healthcare
Moving of healthcare regulatory and enforcement functions to HSA
Overview
Singapore's healthcare regulatory framework is regularly reviewed to ensure that it keeps pace with evolving healthcare delivery models, advances in medical technology, and changing population needs. This framework includes the regulation of healthcare services, products, information, biomedical research and professionals.
Following the latest review, the Ministry of Health (MOH) will be moving the functions of its Health Regulation Group (HRG), and subsequently the Secretariat of healthcare Professional Boards (SPB), to the Health Sciences Authority (HSA) in two phases:
Phase 1 (in November 2026)
MOH HRG’s manpower and functions will move to HSA. These functions include administration, licensing, inspections, audits and enforcement functions related to MOH Acts.
Phase 2 (by end 2027)
SPB’s manpower and functions will move to HSA. These functions include the review and development of policies, guidelines and processes that support the operations and mandate of the Professional Boards and Councils regulating the respective professions.
This move will bring together the regulation of healthcare services, products, information, biomedical research, administrator of healthcare charities and the secretariat support functions of health professional regulation into an integrated regulatory function to better support the rapidly evolving cross-cutting regulatory issues in the healthcare landscape. Over time, HSA will strengthen the integration and coordination across the different regulatory frameworks and redesign its regulatory processes. This will enhance support for licensees and licensed professionals, and provide clearer guidance for the benefit of our stakeholders and the public.
What This Means for You
The key change is the agency responsible for these functions. There is no action required from stakeholders and licensees to reapply for existing licences, approvals or registrations. Existing submission channels, processing arrangements, and regulatory requirements will continue during the transition.
From November 2026, stakeholders and licensees will engage HSA for:
Licensing and approval of healthcare services under the Healthcare Services Act (HCSA)
Notifications and approvals under the Human Biomedical Research Act (HBRA)
Registration of facilities and facility certification bodies under the Biological Agents and Toxins Act (BATA)
Regulatory matters relating to cybersecurity, data security and the National Electronic Health Record (NEHR) under the Health Information Act (HIA)
Health Sector Administrator’s role in the approval and regulation of Charities and Institutions of a Public Character
Registration of health products and licensing of health products dealers under the Health Products Act (HPA)
There will be no change for the regulatory work and processes relating to the registration and other regulatory matters relating to healthcare professionals which will continue to reside with SPB until further communicated by end 2027.
The public can expect a streamlined interface with the regulator, whether they have concerns about a medicine they have purchased, a medical device used in their care, or the healthcare service provider or professional caring for them.
More information will be shared in the upcoming months. If you have feedback or wish to seek clarifications on the above, share with us via go.gov.sg/healthreg-feedback (opens in new tab).
